ArticleJournal of hematology & oncology2022

Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response.

Hanna E Persha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.